Graph | Cluster | Transcripts | Mean logCPM | logFC M26/M2 | FDR M26/M2 | Classification | Human genes | C.elegans genes | Annotation |
---|---|---|---|---|---|---|---|---|---|
|
MligTC455_35967 | Mlig455_038049 | 4.27 | -0.026 | 0.815 | GenAge ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase | abl-1 | Mlig455_038049 {REF} {Length: 6083} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=312.6]; Protein kinase domain [PF00069.27, score=154.8]; SH2 domain [PF00017.26, score=70.5]; Variant SH3 domain [PF14604.8, score=35.2]; SH3 domain [PF00018.30, score=32.7]; Phosphotransferase enzyme family [PF01636.25, score=21.0]} {Human: ENSG00000097007, ABL1, ABL proto-oncogene 1, non-receptor tyrosine kinase, [RH, Score=535, Expect=1e-170]; ENSG00000143322, ABL2, ABL proto-oncogene 2, non-receptor tyrosine kinase, [RH, Score=522, Expect=1e-166]} {Mouse: ENSMUSG00000026842, Abl1, c-abl oncogene 1, non-receptor tyrosine kinase, [RH, Score=533, Expect=1e-170]; ENSMUSG00000026596, Abl2, v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene), [RH, Score=521, Expect=2e-166]} {Dmel: FBgn0000017, Abl, Abl tyrosine kinase, [RH, Score=535, Expect=7e-167]} {Celegans: WBGene00000018, abl-1, Tyrosine-protein kinase abl-1, [RH, Score=503, Expect=2e-158]} {Smed: dd_Smed_v6_4352_0_1, dd_Smed_v6_4352_0_1, [RH, Score=536, Expect=8e-175]} {RNA1509_14302, RNA1509_45756} {RNA1310_8904, RNA1509_45756} {RNA1509_45756, RNA815_5007} {SMEDTYPE: X2; Xins [raj_facs_types]} |